CTRI/2022/04/041701
Completed
N/A
A Proof-Of-Concept, Safety and Efficacy Study of DandruffControl Oil Shots to Evaluate Reduction in Scalp Dandruff inHealthy Adult Human Subjects with Dandruff on Scalp
Brillare Science Private Limited0 sites16 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Brillare Science Private Limited
- Enrollment
- 16
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Age: 18 to 65 years (both inclusive) at the time of consent.
- •2\) Sex: Healthy males and non\-pregnant/non\-lactating females.
- •3\) Females of childbearing potential must have a self\-reported negative pregnancy test.
- •4\) Subjects are generally in good health.
- •5\) Subject has mild to moderate dandruff on scalp determined by ASFS score 24 to 48 with
- •itching and flaking at the screening visit.
- •6\) Subjects have unwashed and untreated scalp for 3\-5 days.
- •7\) All hair colors except grey hair.
- •8\) The subject who does head massage.
- •9\) Subjects with self\-proclaimed nonpathological thinning of hair.
Exclusion Criteria
- •1\) Subjects with a history of severe hair fall due to any clinically significant problems/s like
- •anemia, thyroid problems, etc.
- •2\) History of any dermatological condition of the scalp other than hair loss and/or dandruff.
- •3\) History of prior use of scalp hair growth treatment within 3 months.
- •4\) History of any prior hair growth procedures (e.g., hair transplant or laser).
- •5\) Subjects who have applied topical treatment for hair loss for at least 4 weeks and any
- •systemic treatment for at least 3 months, before they participated in the study.
- •6\) History of alcohol or drug addiction.
- •7\) Subjects using other marketed scalp dandruff control products during the study period.
- •8\) Subjects who have plans of shaving of scalp hair during the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A preliminary safety and efficacy evaluation of direct delivery of autologous bone marrow-derived cells in Egyptian patients with type 1 diabetes mellitusType 1 diabetes mellitusDigestive SystemISRCTN15591075Wadi EL-Neel hospital (JCI)3
Active, Not Recruiting
Phase 1
Can the antibiotic Doxycycline help control the complications (dyskinesias) of levodopa treatment in patients with Parkinson's Disease?RBR-1047fwbfHospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Completed
N/A
The clinical study of the safety and efficacy of docetaxel combined with ribavirin in docetaxel resistant castration resistant prostate cancerJPRN-UMIN000015130Keio University School of Medicine, Department of Urology20
Active, Not Recruiting
Phase 2
PMX-DHP for COVID-19JPRN-jRCTs032200131Izumi Shinnyuu30
Completed
N/A
A study to check the skin safety and effect of SkinQGlow Bright Wonder Mask in Healthy Human Subjects withadequate representation of varied skin types (Normal, Oily,Dry, Combined, and Sensitive skin)CTRI/2022/08/044867Health Q Life Sciences Private Limited38